Founded in 2007 by former Sales-
force employees, Mavens Consut-
ling’s mission is to combine best-in-
class cloud technology and strategic
partnerships to build software solu-
tions that connect people to cures and
elevate the global healthcare indus-
try. Mavens Consulting has grown
into the Life Science industry’s pre-
mier salesforce.com implementation
partner focused exclusively on de-
livering game-changing Salesforce
and Veeva solutions to pharmaceu-
tical and medical device compa-
nies. Mavens was founded by for-
mer Salesforce employees in 2007,
so cloud is in its DNA, says Prasad
Kanumury, CEO of the firm. “We
are a Salesforce Gold Partner and
work together directly with Sales-
force to strengthen our customers’
adoption of the platform,” he says.
In 2014, Mavens won the Salesforce
Partner Innovation Award for Mar-
keting. Each of its consultants holds
multiple Salesforce professional cer-
tifications. At Mavens, “our mission
is to build software solutions that
connect people to cures and elevate
the global healthcare industry. We
can only accomplish that by partner-
ing with the world’s leading tech-
nology providers,” says Kanumury
We work closely with our partners
to bring to life modern cloud tech-
nology solutions that provide our
clients the ability to deliver amaz-
ing experiences to their customers.”
Mavens is headquartered in Chicago
with experts throughout the U.S. and
Europe. Consulting caught up with
Kanumury to discuss the firm’s per-
formance that led to a 108 percent
growth rate, good enough to land the
firm at No. 34 on our Fastest Grow-
ing Firms ranking.
Consulting: What were the main
factors that contributed to your
firm’s exceptional growth?
Kanumury: Our growth in Europe
and our track record of success
through industry specific solutions.
Consulting: How is this year
shaping up for your firm?
Kanumury: We are looking at a 50
percent global head count growth
along with a sizable jump in revenue
over last year.
Consulting: How would you
describe your firm’s outlook for
2017? Where do you see the
Kanumury: Our outlook is an
approximate 30 percent revenue
growth year over year. We will
do this by providing an increased
adoption for industry specific
growth in pharma. I believe Europe
will be our greatest area of opportunity during 2017.
Consulting: What would you
say are your firm’s biggest
challenges in 2017?
Kanumury: The first challenge is
making sure that people are aware
of the solutions we can provide.
The second challenge is competing
with single sourcing mentality in
Consulting: What does being
named one of Consulting’s
Fastest Growing Firms mean to
your firm, your employees and
Kanumury: Consulting is all about
service excellence. It’s about guidance. Moreover, it’s about using
that guidance to help the clients
navigate the unknown. We’re able
to help clients chart new waters.
Showing them how to use the cloud
and connect people to cures. Helping them solve new problems that
will help them achieve their goals.
This award is a reflection of what
we are all about in our business intent. We take a lot of pride in that.